Kerman Dialysis Center, Llc in Kerman, California - Dialysis Center

Kerman Dialysis Center, Llc is a medicare approved dialysis facility center in Kerman, California and it has 17 dialysis stations. It is located in Fresno county at 14945 West Whitebridge Avenue, Kerman, CA, 93630. You can reach out to the office of Kerman Dialysis Center, Llc at (559) 846-0023. This dialysis clinic is managed and/or owned by American Renal Associates. Kerman Dialysis Center, Llc has the following ownership type - Profit. It was first certified by medicare in September, 2016. The medicare id for this facility is 552797 and it accepts patients under medicare ESRD program.

Name	Kerman Dialysis Center, Llc
Location	14945 West Whitebridge Avenue, Kerman, California
No. of Dialysis Stations	17
Medicare ID	552797
Managed By	American Renal Associates
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Kerman Dialysis Center, Llc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1467847202
Doing Business As	Kerman Dialysis Center Llc
Address	14945 W Whitesbridge Ave Kerman, California, 93630
Phone Number	(559) 846-0023

Dialysis patients with Hemoglobin data	28
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL	39

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	50
  Adult patient months included in Kt/V greater than or equal to 1.2	364
  Percentage of adult patients getting regular hemodialysis at the center	95
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Kerman Dialysis Center, Llc with elevated calcium levels.

Patients with hypercalcemia	51
Hypercalcemia patient months	370
Hypercalcemia patients with serumcalcium greater than 10.2 mg	1
Patients with Serumphosphor	56
Patients with Serumphosphor less than 3.5 mg/dL	7
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	26
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	36
Patients with Serumphosphor from 5.6 to 7 mg/dL	19
Patients with Serumphosphor greater than 7 mg/dL	12

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	46
Patient months included in arterial venous fistula and catheter summaries	320
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	72
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	16

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	5
Hospitalization Rate in facility	(Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit